Abstract
Maintenance treatment with chrysotherapy was given to 44 rheumatoid patients after a total of 1.0 g weekly injections of sodium aurothiomalate. 21 patients continued with 50 mg injections every 2 weeks, and 23 patients received the same dose at 4-week intervals. Their progress was followed over 1 year, after which time their clinical improvements were equally well sustained. Toxicity was greater in those patients receiving fortnightly injections. Five patients suffered a relapse after 8 months. These were not related to the frequency of injections nor to the serum gold levels. There appeared to be no advantage in maintenance injections at fortnightly intervals.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Billings R., Grahame R., Marks V., Wood P. J., Taylor A. Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatol Rehabil. 1975 Feb;14(1):13–18. doi: 10.1093/rheumatology/14.1.13. [DOI] [PubMed] [Google Scholar]
- Cats A. A multicentre controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage. Agents Actions. 1976 Feb;6(1-3):355–363. doi: 10.1007/BF01972255. [DOI] [PubMed] [Google Scholar]
- Furst D. E., Levine S., Srinivasan R., Metzger A. L., Bangert R., Paulus H. E. A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1473–1480. doi: 10.1002/art.1780200805. [DOI] [PubMed] [Google Scholar]
- Griffin A. J., Gibson T., Taylor A. Comparison of two maintenance schedules of chrysotherapy in rheumatoid arthritis: preliminary report. Rheumatol Rehabil. 1978;Suppl:99–104. doi: 10.1093/rheumatology/xvii.suppl.99. [DOI] [PubMed] [Google Scholar]
- Jessop J. D., Johns R. G. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate. Ann Rheum Dis. 1973 May;32(3):228–232. doi: 10.1136/ard.32.3.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kean W. F., Anastassiades T. P. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods. Arthritis Rheum. 1979 May;22(5):495–501. doi: 10.1002/art.1780220509. [DOI] [PubMed] [Google Scholar]
- Lorber A., Atkins C. J., Chang C. C., Lee Y. B., Starrs J., Bovy R. A. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis. Ann Rheum Dis. 1973 Mar;32(2):133–139. doi: 10.1136/ard.32.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luukkainen R., Isomäki H., Kajander A. Effect of gold treatment on the progression of erosions in RA patients. Scand J Rheumatol. 1977;6(2):123–127. doi: 10.3109/03009747709095434. [DOI] [PubMed] [Google Scholar]
- Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
- Rothermich N. O., Philips V. K., Bergen W., Thomas M. H. Followup study of chrysotherapy. Arthritis Rheum. 1979 Apr;22(4):423–423. doi: 10.1002/art.1780220418. [DOI] [PubMed] [Google Scholar]
- Sharp J. T., Lidsky M. D., Collins L. C., Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 1971 Nov-Dec;14(6):706–720. doi: 10.1002/art.1780140605. [DOI] [PubMed] [Google Scholar]
- Sigler J. W., Bluhm G. B., Duncan H., Sharp J. T., Ensign D. C., McCrum W. R. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med. 1974 Jan;80(1):21–26. doi: 10.7326/0003-4819-80-1-21. [DOI] [PubMed] [Google Scholar]
- Srinivasan R., Miller B. L., Paulus H. E. Long-term chrysotherapy in rheumatoid arthritis. Arthritis Rheum. 1979 Feb;22(2):105–110. doi: 10.1002/art.1780220201. [DOI] [PubMed] [Google Scholar]